This study highlights the utility of Hepatica for identifying patients at increased risk of poor post-operative liver performance and longer hospital stay. Pre-operative cT1 predicts length of post-operative hospital stay and has potential to inform the individualised risk assessment and surgical decision-making for liver cancer surgery.